ClinicalTrials.Veeva

Menu

Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

C

Chinese PLA General Hospital (301 Hospital)

Status

Enrolling

Conditions

Diabetic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03865914
S2017-133-01

Details and patient eligibility

About

With the rapid increase of diabetic nephropathy worldwide, type 2 diabetes mellitus(DM) is the leading cause of end-stage renal disease(ESRD). Pathological types of diabetic kidney disease(DKD) could be mainly divided into diabetic nephropathy(DN)and non-diabetic renal diseases(NDRD). There are no accurate renal biopsy indications and standardized operation procedures for type 2 diabetic nephropathy. The clinical stages of type 2 diabetic nephropathy still referred to the Mogensen stage of type 1 diabetic nephropathy. Thus, our study aim to clarify the differences in clinical phenotype between type 2 DN and type 2 NDRD, analysis the correlation between clinical and pathological features, and offer the criteria for clinical staging and prognosis.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age≥18, male or female
  • Clinical diagnosed as type 2 diabetes mellitus
  • The presence of renal impairment including: microalbuminuria or overt proteinuria or renal insufficiency
  • The renal biopsy was performed with complete renal pathological diagnosis
  • Obtaining the signed informed consent from patients

Exclusion criteria

  • The history of the disease was not complete
  • Clinical diagnosed as other secondary renal diseases
  • Patients with hereditary kidney disease
  • Autoimmune diseases
  • Patients with malignant tumor were expected to survive less than 6 months
  • Pregnancy and lactation

Trial design

2,000 participants in 1 patient group

Type 2 diabetic nephropathy
Description:
The cohort will be followed for at least 10 years. The cohort will be divided into 2 groups according the pathological results of patients,and at least 3 groups according to clinical features such as renal function and proteinuria.

Trial contacts and locations

1

Loading...

Central trial contact

Xiangmei Chen, MD.&Ph.D; Zheyi Dong, MD.&Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems